Idexx Laboratories (IDXX) Cash from Operations Growth (1y) (2010 - 2026)
Powered by 
Analysis
Idexx Laboratories (IDXX) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 86.90% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 8.26% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 16.88% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 13.27% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 27.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86.90% |
| Mar 31, 2026 | 11.89% |
| Dec 31, 2025 | 35.77% |
| Sep 30, 2025 | 82.82% |
| Jun 30, 2025 | -25.20% |
| Mar 31, 2025 | 19.83% |
| Dec 31, 2024 | 4.87% |
| Sep 30, 2024 | -19.22% |
| Jun 30, 2024 | 23.96% |
| Mar 31, 2024 | 7.98% |
| Dec 31, 2023 | 44.07% |
| Sep 30, 2023 | 44.14% |
| Jun 30, 2023 | 204.20% |
| Mar 31, 2023 | 60.33% |
| Dec 31, 2022 | -17.40% |
| Sep 30, 2022 | 0.96% |
| Jun 30, 2022 | -71.85% |
| Mar 31, 2022 | -7.81% |
| Dec 31, 2021 | -4.10% |
| Sep 30, 2021 | -3.06% |